CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Caplin Point Laboratories Limited Company Snapshot
Caplin Point Laboratories Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Caplin Point Laboratories Limited with three other companies in this sector in India: Wanbury Limited (2017 sales of 4.37 billion Indian Rupees [US$67.81 million] ), Sterling Biotech Ltd (3.68 billion Indian Rupees [US$57.22 million] ), and Venus Remedies Ltd (4.00 billion Indian Rupees [US$62.13 million] ).

Sales Analysis. Caplin Point Laboratories Limited reported sales of 4.02 billion Indian Rupees (US$62.38 million) for the fiscal year ending March of 2017. This represents an increase of 30.2% versus 2016, when the company's sales were 3.08 billion Indian Rupees. Sales at Caplin Point Laboratories Limited have increased during each of the previous five years (and since 2012, sales have increased a total of 286%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Caplin Point Laboratories Limited
  Stock Performance Chart for Caplin Point Laboratories Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 711.85
(Figures in Indian Rupees)
1 Week -0.9%   13 Weeks 22.4%  
4 Weeks 77.1%   52 Weeks 204.6%  
 
Caplin Point Laboratories Limited Key Data:
  Ticker: CAPLIPOINT Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 4,016,485,000
(Year Ending Jan 2018).
Employees: 570
  Currency: Indian Rupees Market Cap: 53,799,309,488
  Fiscal Yr Ends: March Shares Outstanding: 75,576,750
  Share Type: Ordinary Closely Held Shares: 53,265,025
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.